Plasmodium gallinaceum: use of antisera to degenerate synthetic peptides derived from the active site of protozoal chitinases to characterize an ookinete-specific chitinase.
Vinetz
J M
JM
Malaria Vaccines Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892-0425, USA.
Kaslow
D C
DC
D000595:Amino Acid Sequence; D000818:Animals; D002688:Chitinases / Q000737:chemistry / Q000276:immunology*; D017124:Conserved Sequence; D004591:Electrophoresis, Polyacrylamide Gel; D007106:Immune Sera / Q000276:immunology*; D015151:Immunoblotting; D010964:Plasmodium gallinaceum / Q000201:enzymology* / Q000276:immunology
D007106:Immune Sera; D002688:Chitinases